Cited by 45Chemokine receptors and signalingAdipokines, Inflammation, and Metabolic DiseasesInflammation biomarkers and pathways

Leukocyte cell-derived chemotaxin-2: it's role in pathophysiology and future in clinical medicine

Open access
Slowik, V, Apte, U·2017·Clinical and Translational Science

Abstract

INTRODUCTIONLeukocyte cell-derived chemotaxin-2 (LECT2) is a highly conserved protein with roles in cell development, sepsis, liver disease, metabolic syndrome, arthritis, cancer, and amyloidosis, among others.We will review its genetics, structure, role in physiology, and its future as a biomarker and therapeutic target across many diseases.Studies involving LECT2 were identified using PubMed and compiled into a single review paper.Research on LECT2 suggests a future as a biomarker of disease and potential therapeutic target. BACKGROUNDThe discovery of leukocyte cell-derived chemotaxin-2 (LECT2) was the result of a drive to find novel biomarkers of inflammatory diseases.1 It was first isolated in humans by Yamagoe et al. 1 from phytohemagglutinin-stimulated T-cell leukemia SKW-3 cells and identified as a chemotaxin of neutrophils.Chemotaxins are substances released by cells that stimulate the movement of white blood cells and LECT2 derived its name from this in vitro chemotactic ability at its initial discovery.1 However, it is now known to have several other functions in the human body and it is no longer limited to chemotaxis.There has been a rapid expansion of knowledge regarding its function with major developments in liver regeneration, 2-8 immune modulation, 1,9-15 bone growth, 9,[16][17][18][19][20] neuronal development, 21 glucose metabolism and metabolic syndrome, 10,22-27 cancer, 9,28-33 and amyloidosis, [34][35][36][37][38][39] among others.It is often found secreted in the bloodstream and expression of this protein has been identified in liver cells, neurons, various epithelial cells, parathyroid cells, and white blood cells, although it is felt to be most often secreted by the liver. 40However, despite the multifunctional role of LECT2 in several different organ systems, there has yet to be a comprehensive review that summarizes all of the current knowledge and information.We will attempt to synthesize current reported literature on this increasingly important protein and explore its potential future in modern clinical medicine in relation to disease pathophysiology (Table 1) 6,13,17,18,22,28,29,33,41,42 and as a biomarker (Table 2).2,3,6,[9][10][11][12][13][14][15][16][17][18][19][22][23][24][28][29][30][31][33][34][35][36][37][38][39][40][41][42]

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cts.12469

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tissues normally lacking LECT2 exhibit increased expression of LECT2 in disease settings, indicating improper upregulation of LECT2 may contribute to pathological conditions.

    “Interestingly, tissues normally lacking LECT2 exhibit increased expression of LECT2 in disease settings, indicating that improper upregulation of LECT2 may contribute to pathological conditions [246,247].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Slowik, V, & Apte, U.
Affiliations
  • Children's Mercy Hospital (US)
  • University of Kansas Medical Center (US)
Corresponding author
Slowik, V
Venue
Clinical and Translational Science
Publisher
Wiley
Published
2017-05-23
Volume
10
Issue
4
Pages
249-259
ISSN
  • 1752-8054 (ISSN-L)
  • 1752-8062
OpenAlex
W2610218880
Cited by
44
References
54
Citations by year
2026: 3 · 2025: 2 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 9 · 2020: 6 · 2019: 4
FWCI
0.29
Type
journal article
Language
en
Open access
Locations
  • Clinical and Translational Science (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Keywords
LECT2, biomarkers, therapeutic target, liver regeneration, sepsis, metabolic syndrome, cancer, amyloidosis, immunomodulation, bone growth, glucose metabolism, neutrophil chemotaxis, liver disease, inflammation, disease pathophysiology, clinical translation
MeSH terms
Amyloidosis, Animals, Cell Cycle, Disease Models, Animal, Humans, Immune System, Leukocytes, Liver Regeneration, Neoplasms, Osteoarthritis, Biomarkers, Sepsis, Metabolic Syndrome, Intercellular Signaling Peptides and Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review